Literature DB >> 10966491

Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease.

Kathryn Elizabeth White1, Rudolf William Bilous2.   

Abstract

Glomerular structural-functional relationships were investigated in 21 type 2 diabetic patients with proteinuria. Structural parameters were quantified using both light and electron microscopy and standard stereologic techniques. Data were also available on 14 nondiabetic subjects. Mesangial and matrix volume fractions and glomerular basement membrane (GBM) width were increased in type 2 patients when compared with nondiabetic subjects (mean +/- SD: 0.45 +/- 0.13 versus 0.18 +/- 0.03, P: < 0.001; 0.28 +/- 0.09 versus 0.10 +/- 0.02, P: < 0.001; and 665 +/- 138 versus 361 +/- 51 nm, P: < 0. 001, respectively). An increase in mesangial volume fraction was associated with high levels of proteinuria and low creatinine clearance (r = 0.64, P: = 0.002; r = -0.58, P: = 0.006, respectively). GBM width and mesangial foot process width (FPW(mes)) also correlated with proteinuria (r = 0.58, P: = 0.006; r = 0.60, P: = 0.004, respectively). Volume fraction of interstitium correlated with creatinine clearance (r = -0.58, P: = 0.006). Patients had previously been defined by light microscopy as having either diffuse or nodular glomerulosclerosis; those with nodules had larger mesangial and matrix volume fractions and more proteinuria than those classified as diffuse (mean +/- SD: 0.51 +/- 0.12 versus 0.36 +/- 0.08, P: = 0.007; 0.32 +/- 0.08 versus 0.21 +/- 0.05, P: = 0. 003; median, range: 4.3, 1.1 to 9.6 versus 1.1, 0.9 to 12.7 g/24 h, P: = 0.027). Creatinine clearance did not differ significantly between the groups. Type 2 diabetic patients with proteinuria have established glomerulopathy, which is more advanced in those with nodular glomerulosclerosis. Creatinine clearance correlated with both mesangial and interstitial expansion, whereas proteinuria correlated only with glomerular pathology. These results suggest that type 2 patients with advanced nephropathy have structural-functional relationships similar to type 1, consistent with a common pathogenesis, and strongly support an important role of the tubulointerstitium in the role of renal impairment.

Entities:  

Mesh:

Year:  2000        PMID: 10966491     DOI: 10.1681/ASN.V1191667

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  54 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

2.  The effect of intrauterine environment and low glomerular number on the histological changes in diabetic glomerulosclerosis.

Authors:  S E Jones; K E White; A Flyvbjerg; S M Marshall
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 3.  Associations between structural and functional changes to the kidney in diabetic humans and mice.

Authors:  David W Powell; David N Kenagy; Shirong Zheng; Susan C Coventry; Jianxiang Xu; Lu Cai; Edward C Carlson; Paul N Epstein
Journal:  Life Sci       Date:  2013-06-22       Impact factor: 5.037

Review 4.  Update on blood pressure control and renal outcomes in diabetes mellitus.

Authors:  Mark Henry Joven; Robert J Anderson
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 5.  Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.

Authors:  So-Young Lee; Mary E Choi
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

6.  Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Emad M Masuadi; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-01-05       Impact factor: 3.396

7.  Pyridorin in type 2 diabetic nephropathy.

Authors:  Edmund J Lewis; Tom Greene; Samuel Spitalewiz; Samuel Blumenthal; Tomas Berl; Lawrence G Hunsicker; Marc A Pohl; Richard D Rohde; Itamar Raz; Yair Yerushalmy; Yoram Yagil; Tommy Herskovits; Robert C Atkins; Anne T Reutens; David K Packham; Julia B Lewis
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

8.  Deacetylation of S6 kinase promotes high glucose-induced glomerular mesangial cell hypertrophy and matrix protein accumulation.

Authors:  Falguni Das; Soumya Maity; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2019-04-26       Impact factor: 5.157

Review 9.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

10.  The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

Authors:  P Fioretto; M L Caramori; M Mauer
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.